Bacillus Calmette-Guerin (BCG) balanitis as a complication of intravesical BCG immunotherapy: A case report

1995 ◽  
Vol 27 (3) ◽  
pp. 307-310 ◽  
Author(s):  
A. Erol ◽  
S. Özgür ◽  
N. Tahtali ◽  
E. Akbay ◽  
I. Dalva ◽  
...  
Keyword(s):  
Case Report ◽  
Bacillus Calmette Guerin ◽  
Bcg Immunotherapy ◽  
Intravesical Bcg

scholarly journals Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer

2019 ◽  
Vol 2019 ◽  
pp. 1-11 ◽  
Author(s):  
Yuqing Liu ◽  
Jian Lu ◽  
Yi Huang ◽  
Lulin Ma
Keyword(s):  
Bladder Cancer ◽  
Adverse Reactions ◽  
Clinical Manifestations ◽  
Bacillus Calmette Guerin ◽  
Bcg Immunotherapy ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Proven Efficacy ◽  
Bcg Instillation ◽  
Early Establishment

Because of its proven efficacy, intravesical Bacillus Calmette-Guérin (BCG) immunotherapy is an important treatment for nonmuscle invasive bladder cancer at high risk of recurrence or progression. However, approximately 8% of patients have to stop BCG instillation as a result of its complications. Complications induced by BCG therapy can have a variety of clinical manifestations. These adverse reactions may occur in conjunction with BCG instillation or may not develop until months or years after BCG cessation. An essential step in the management complications arising from BCG is early establishment of diagnosis, particularly for distant, disseminated, and obscure infections. Therefore we reviewed the literature on the potential complications after intravesical BCG immunotherapy for bladder cancer and provide an overview on the incidence, diagnosis, and treatment modality of genitourinary and systemic BCG-induced complications.

CASE REPORT Reactive arthritis after application of intravesical BCG immunotherapy in bladder cancer

2009 ◽  
Vol 62 ◽  
pp. 266-267
Author(s):  
Artur Chmiel ◽  
Joanna Wierzbicka-Chmiel ◽  
Krzysztof Wierzbicki ◽  
Tadeusz Dzielski ◽  
Jolanta Gil
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Reactive Arthritis ◽  
Bcg Immunotherapy ◽  
Intravesical Bcg

Disseminated Bacillus Calmette-Guerin (BCG-osis) in an Immunocompetent Adult After Intravesical BCG Immunotherapy

CHEST Journal ◽  
2014 ◽  
Vol 146 (4) ◽  
pp. 191A ◽  
Author(s):  
Richard May ◽  
Chinenye Emuwa ◽  
Amee Patrawalla ◽  
Andrew Berman
Keyword(s):  
Bacillus Calmette Guerin ◽  
Immunocompetent Adult ◽  
Bcg Immunotherapy ◽  
Intravesical Bcg

scholarly journals Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature

2018 ◽  
Vol 2018 ◽  
pp. 1-7
Author(s):  
Nigel P. Murray ◽  
Cynthia Fuentealba ◽  
Isidora Salazar ◽  
Aníbal Salazar ◽  
Marco Antonio Lopez ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Superficial Bladder Cancer ◽  
Spontaneous Remission ◽  
Bacillus Calmette Guerin ◽  
Review Of The Literature ◽  
Intravesical Bcg

Myelodysplasia is a clonal disorder characterized by progressive cytopenias. Intravescial BCG is standard immunotherapy for superficial bladder cancer. We present a patient with transfusion-dependent myelodysplasia whose blood counts normalized during treatment with intravesical BCG for bladder cancer. After finishing treatment, the patient became transfusion dependent once more. We discuss possible mechanisms to explain this case report.

Reiter's syndrome (reactive arthritis) with trismus after intravesical BCG immunotherapy: A case report

2011 ◽  
Vol 23 (1) ◽  
pp. 25-27 ◽  
Author(s):  
Noriko Hatano ◽  
Hisako Hikiji ◽  
Minoru Matsubara ◽  
Hideto Saijo ◽  
Daichi Chikazu ◽  
...  
Keyword(s):  
Case Report ◽  
Reactive Arthritis ◽  
Reiter's Syndrome ◽  
Bcg Immunotherapy ◽  
Reiter’S Syndrome ◽  
Intravesical Bcg
Sign in / Sign up

Export Citation Format

Share Document